Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liu Wei

Showing results (251-260 of 255) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 255 results.
The Journal of Experimental Medicine|February 26, 2014
Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradicationDavid A Nathanson, Amanda L Armijo, Michelle Tom, et al.
Theranostics|January 2, 2015
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferonFeng-Qin Hou, Liu-Wei Song, Quan Yuan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agentsFumiaki Yokokawa, Gang Wang, Wai Ling Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activityWoosuk Kim, Thuc M Le, Liu Wei, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
Pageof 26

Showing results (251-260 of 255) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 255 results.
The Journal of Experimental Medicine|February 26, 2014
Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradicationDavid A Nathanson, Amanda L Armijo, Michelle Tom, et al.
Theranostics|January 2, 2015
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferonFeng-Qin Hou, Liu-Wei Song, Quan Yuan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agentsFumiaki Yokokawa, Gang Wang, Wai Ling Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activityWoosuk Kim, Thuc M Le, Liu Wei, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
Pageof 26